Revenue Recognition (Tables)

6 Months Ended

Jun. 30, 2018

Selective enterprise information of sales disaggregated by category and geographic region is as follows:

	Three Months Ended June 30, 2018				Six Months Ended June 30, 2018
	As reported		Without adoption of ASC 606		As reported		Without adoption of ASC 606
Net sales:
Crop:
Insecticides	$	32,665	$	32,671	$	73,958	$	73,988
Herbicides/soil fumigants/fungicides		31,401		31,401		63,586		63,586
Other, including plant growth regulators and distribution		30,377		30,377		48,217		48,217
		94,443		94,449		185,761		185,791
Non-crop, including distribution		12,603		12,603		25,393		25,393
Total net sales:	$	107,046	$	107,052	$	211,154	$	211,184
Net sales:
US	$	64,363	$	64,369	$	134,178	$	134,208
International		42,683		42,683		76,976		76,976
Total net sales:	$	107,046	$	107,052	$	211,154	$	211,184
Timing of revenue recognition:
Goods transferred at a point in time	$	106,886	$	107,052	$	210,591	$	211,184
Goods and services transferred over time		160		—		563		—
Total net sales:	$	107,046	$	107,052	$	211,154	$	211,184

The following table presents the effect of the adoption of ASC 606 on our condensed consolidated balance sheet (unaudited) as of December 31, 2017:

	As of December 31, 2017
	As previously reported		Adjustment due to adoption of ASC 606		As adjusted
Total assets	$	535,592	$	3,000	$	538,592
Deferred income tax liabilities, net		16,284		786		17,070
Retained earnings		238,953		2,214		241,167

In accordance with ASC 606, the disclosure of the impact of adoption to our condensed consolidated balance sheets was as follows:

	As of June 30, 2018
	As reported		Balances without adoption of ASC 606		Impact
Assets:
Contract assets	$	3,000	$	—	$	3,000
Current liabilities:
Deferred revenue		7,320		7,263		57
Deferred income tax liabilities		786		—		786
Stockholders' equity:
Retained earnings		250,068		247,854		2,214